Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeStem CellsRemission InductionHematologic NeoplasmsSalvage TherapyBone Marrow TransplantationMyeloablative AgonistsRecurrenceDisease-Free SurvivalCyclophosphamideHodgkin DiseaseEtoposideSurvival RateBusulfanCytarabineLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationSurvival AnalysisTransplantation ChimeraWhole-Body IrradiationGraft SurvivalRetrospective StudiesCarmustineHematopoietic Stem CellsVincristineTissue DonorsThiotepaBone Marrow PurgingPrognosisLiver TransplantationFollow-Up StudiesLymphoma, Mantle-CellGraft vs Leukemia EffectAntigens, CD34Leukemia, Myeloid, AcuteAmyloidosisTime FactorsMesenchymal Stem Cell TransplantationNeoplasm, ResidualCord Blood Stem Cell TransplantationAntibodies, Monoclonal, Murine-DerivedDoxorubicinHistocompatibility TestingAntineoplastic AgentsVidarabineLymphoma, FollicularBoronic AcidsDexamethasonePyrazinesImmunosuppressive AgentsGraft vs Tumor EffectMyelodysplastic SyndromesGranulocyte Colony-Stimulating FactorAntineoplastic Agents, AlkylatingLeukemiaCell TransplantationLymphomaThalidomideAutograftsLymphoma, T-Cell, PeripheralLeukapheresisKidney TransplantationIfosfamideHistocompatibilityEmbryonic Stem CellsInduction ChemotherapyLymphocyte TransfusionPrednisonePrecursor Cell Lymphoblastic Leukemia-LymphomaPodophyllotoxinAdult Stem CellsSiblingsT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseLeukemia, MyeloidLymphoma, Large B-Cell, DiffuseCytomegalovirus InfectionsMaintenance ChemotherapyProspective StudiesLymphocyte DepletionHepatic Veno-Occlusive DiseaseAntilymphocyte SerumChimerismAntibodies, MonoclonalFatal OutcomeTransplantation ImmunologyCell DifferentiationMinor Histocompatibility Antigens